Principal Securities, Inc. Immunocore Holdings PLC Transaction History
Principal Securities, Inc.
- $4.44 Trillion
- Q4 2024
A detailed history of Principal Securities, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Principal Securities, Inc. holds 96 shares of IMCR stock, worth $2,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96
Previous 72
33.33%
Holding current value
$2,884
Previous $2.24 Million
26.37%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMCR
# of Institutions
133Shares Held
41.2MCall Options Held
197KPut Options Held
424K-
Wellington Management Group LLP Boston, MA7.05MShares$212 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$195 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$146 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$74.3 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$64.8 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.32B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...